LobbyingVivant Behavioral Healthcare lobbying by quarter
Vivant Behavioral Healthcare's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Vivant Behavioral Healthcare
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $40K | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $40K | 1 |
| Q4 2023 | $40K | 1 |
| Q1 2024 | $40K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$173.3K · 15 reports
- Medical research and clinical labs$173.3K · 15 reports
- Medicare and Medicaid$173.3K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Buchanan Ingersoll & Rooney PC | $520K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| AMANDA LINCOLN | Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins | Q4 2025 |
| EDWARD HILD | Chief of Staff, Sen. Lisa Murkowski; Legislative Director, Sen. Pete Domenici | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Buchanan Ingersoll & Rooney PC | $40K |
| 04/20for Q1 | Buchanan Ingersoll & Rooney PC | $40K |
| 01/20for Q4 2025 | Buchanan Ingersoll & Rooney PC | $40K |
| 25/10/20for Q3 2025 | Buchanan Ingersoll & Rooney PC | $40K |
| 25/07/22for Q2 2025 | Buchanan Ingersoll & Rooney PC | $40K |
| 25/04/21for Q1 2025 | Buchanan Ingersoll & Rooney PC | $40K |
| 25/01/21for Q4 2024 | Buchanan Ingersoll & Rooney PC | $40K |
| 24/10/21for Q3 2024 | Buchanan Ingersoll & Rooney PC | $40K |
| 24/07/22for Q2 2024 | Buchanan Ingersoll & Rooney PC | $40K |
| 24/04/18for Q1 2024 | Buchanan Ingersoll & Rooney PC | $40K |
| 24/01/22for Q4 2023 | Buchanan Ingersoll & Rooney PC | $40K |
| 23/10/20for Q3 2023 | Buchanan Ingersoll & Rooney PC | $40K |
| 23/07/19for Q2 2023 | Buchanan Ingersoll & Rooney PC | Under $5,000 |
| 23/04/20for Q1 2023 | Buchanan Ingersoll & Rooney PC | Under $5,000 |
| 23/01/13for Q4 2022 | Buchanan Ingersoll & Rooney PC | $40K |